NCT07125040View on ClinicalTrials.gov

Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers

RecruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2028

Conditions
LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\)Merosin Deficient CMD (Full or Partial)Merosin Deficient Congenital Muscular Dystrophy
Interventions
OTHER

Cardiac MRI

On a subset of adult patients

Trial Locations (1)

20132

RECRUITING

Irccs Ospedale San Raffaele, Milan

All Listed Sponsors
lead

Università Vita-Salute San Raffaele

OTHER